ITNS Insider
Jul. 2, 2015

Submit an Abstract for 2016!
Submit an abstract for the 25th Annual ITNS Symposium before the October 13, 2015 deadline. Join us from 14-16 October 2016 at The Westin Pittsburgh for Transplant Nursing: Bridging Passion, Practice, and Patient Care. Questions about abstract submission? Contact Jennifer Wahl, ITNS Education Manager, at

CIMI-BRIGHT Validation Survey
This online survey is a substudy of the Building research initiative group: chronic illness management and adherence in transplantation (BRIGHT) study, an international, multicenter, cross-sectional research project that was launched and conducted in partnership with ITNS. More information on BRIGHT is available in the study protocol published in the Journal of Advanced Nursing (Berben et al., 2014). This substudy is designed to evaluate the CIMI-BRIGHT questionnaire developed for the BRIGHT study. You will be asked to provide some demographic information about you and your transplant center and then to complete the CIMI-BRIGHT questionnaire. This questionnaire asks about practice patterns used in your everyday work and competencies of the healthcare professionals working in your center. For example, it asks how patients' medication adherence is assessed or how the follow up care of transplant patients in your transplant program is organized. The proposal for the study was reviewed and approved by the ethics committee Nordwest- und Zentralschweiz, Switzerland on April 28, 2015.

Click here to take the CIMI-BRIGHT Validation Study. More

ITNS Chapters
Email your chapter events to to get it listed on the ITNS calendar. This is a free membership benefit and a great way to promote chapter events! We are also happy to include your chapter events here in the ITNS Insider!More

Study: Organ donation gap isn't due to racial disparity
By Chelsea Adams
New research in the American Journal of Transplantation shows geographic gaps in organ donation rates are not due to the prevalence of racial or ethnic populations — a common belief among solid organ transplant. Researchers at the University of Pennsylvania and the University of Kansas looked at data from on all "eligible deaths." Eligible deaths are potential brain-dead organ donors age 70 years or less without any medical conditions that would prevent organ donation. More

'Recycled' kidney donated to second recipient after first dies
Fox News
A Romanian man who donated his kidney to his son agreed to donate the same organ to a different recipient after his son suddenly died, Central European News reported. Three months ago, the unnamed father initially donated his kidney to his 36-year-old son, who was critically ill after his own kidneys had stopped working. The younger man died suddenly of a massive stroke.More

4 lives saved through organ transplant in Delhi
The Statesman
A-42-year-old person, who was declared brain dead at a private hospital here, saved the life of four people after his family members consented to donating his organs including the heart and both kidneys. More

Action to combat organ transplant abuse in China
New Zealand Doctor Online
Nobel Peace Prize nominee and renowned human rights lawyer will be visiting Wellington on July 1. Author of Bloody Harvest and State Organs, David is known globally for his investigation into the organ harvesting trade in China which uncovered one of the world's worst crimes against humanity.More

Why are Australian organ donation rates so low?
BBC News
Despite investing heavily in its organ donation system in recent years, the Australian government is again asking why donor numbers have failed to rise significantly.More

New bill could decide fate of marijuana users awaiting organ transplants
LA Weekly
Awakening each morning in pain caused by various surgeries, Yami Bolanos engages in her daily routine of relief, which she finds only with cannabis oil. A cancer survivor who underwent a liver transplant 19 years ago, she is now in need of another organ donation. But like others who use cannabis for relief, Bolanos, a 58-year-old resident of Santa Monica, has been kicked off the waiting list of potential organ recipients.More

Hold smartphones away from cardiac devices
HealthDay News via Renal & Urology News
Smartphones should be kept a safe distance from implanted cardiac devices like pacemakers and defibrillators, in the rare chance that signaling interference occurs, according to new research. The findings were scheduled to be presented Monday at the joint meeting of the European Heart Rhythm Association of the European Society of Cardiology and Cardiostim in Milan.More

The impact of hepatitis E in the liver transplant setting
Journal of Hepatology
Hepatitis E virus (HEV) infection has been identified as a cause of graft hepatitis in liver transplant recipients. The true frequency and clinical importance of HEV infections after liver transplantations is a matter of debate. It is proposed that consumption of HEV-contaminated undercooked meat is a main source for HEV infections in developed countries — which might also account for some hepatitis E cases after organ transplantation.More

Kidney transplantation in patients with severe preoperative hypertension
Clinical Transplantation
Severe systemic hypertension is a risk factor for perioperative cardiovascular complications; however its impact at the time of kidney transplantation is not well defined. A retrospective cohort study of adult kidney-only transplant recipients between 10/09-12/12 was performed to examine outcomes between patients with (n=111) and without (n=98) severe preoperative HTN defined as SBP greater than 180 or DBP greater than 110 mmHg.More

Arterial hypertension in children with hemolytic uremic syndrome after kidney transplantation
Pediatric Transplantation
The development of arterial hypertension after KTX is a well-known complication. HUS is a systemic disease associated with arterial hypertension during long-term follow-up. Our goal was to report on the severity of arterial hypertension after KTX in patients with typical and atypical HUS. We analyzed the course of 197 patients with HUS, of which 22 (n = 10 with typical HUS; n = 12 with atypical HUS) developed ESRF and received KTX as renal replacement therapy. More